Human trials of 2nd local COVID-19 vaccine expected in January
The Institute of Vaccines and Medical Biologicals (IVAC), based in central Khanh Hoa province, has proposed the Ministry of Health allow human trials of its COVID-19 vaccine to begin in January, two months ahead of schedule.
A medial worker prepares to inject Nanocovax, the first made-in-Vietnam COVID-19 vaccine, into a volunteer as part of human trials on December 17, 2020 (Photo: VNA)
Khanh Hoa (VNA) – The Institute of Vaccines andMedical Biologicals (IVAC), based in central Khanh Hoa province, has proposedthe Ministry of Health allow human trials of its COVID-19 vaccine to beginin January, two months ahead of schedule.
The IVAC said it made the proposal following the testing onanimals like hamsters, mice, and rabbits, which has shown that the candidate vaccineis safe and creates high immune response on the animals.
If permitted, this will be the second Vietnamese vaccine inclinical trials on humans, after Nanocovax of the NanogenPharmaceutical Biotechnology JSC, which started the first phase of human trialson December 10, 2020.
IVAC Director Duong HuuThai said the institute’s research on a COVID-19 vaccine began in May, aimingto successfully produce a vaccine and complete three phases of clinical trialsin 18 months.
“Initial results arerelatively goods,” he said, noting that the first phase of testing will lastfor about two months and conclude in April.
If all the three phases showgood results, the vaccine will be available as soon as late 2021, Thaiadded.
The IVAC is set to coordinate with the National Institute ofHygiene and Epidemiology (NIHE) and the Hanoi Medical University to conduct clinical trials.
Different dosages of the vaccine will be injected into 125volunteers of various age groups.
Apart from the IVAC’s vaccine and Nanocovax, Vietnam alsohas some other COVID-19 candidate vaccines being developed./.
Prime Minister Nguyen Xuan Phuc on December 21 asked vaccine research units to take strong measures, and suitable and creative methods to speed up vaccine trials in the country.
Seventeen more volunteers were injected with Nanocovax, the first COVID-19 vaccine developed by Vietnam, by the Military Medical University in the morning of December 22.
The United Nations General Assembly approved Vietnam’s initiative with a resolution proclaiming December 27 as the International Day of Epidemic Preparedness. Prime Minister Nguyen Xuan Phuc delivered a message on the Day (December 27,2020).
Vietnam was a bright spot in 2020 for its success in controlling the COVID-19 pandemic, protecting people’s health and maintaining stable economic development in the context of the world struggling to cope with the crisis.
Despite storm-related disruptions and flight delays, the organs were successfully transported via a combination of air and ground travel. All patients are currently stable and recovering well.
The patient, Tieu Viet But, born in 1970 and residing in Binh Tri commune, Binh Son district, the central province of Quang Ngai, was working aboard fishing vessel Qng – 95657TS when the incident occurred at 7:00 am.
All drugs entering hospitals must have a clear origin, so counterfeit drugs are only in the market, not in hospital, affirmed Minister of Health Dao Hong Lan.
To achieve its goal of becoming a developed nation by 2045, Vietnam is prioritising the integration of AI and digital tools into the training of future doctors, said Assoc. Prof. Dr. Nguyen Viet Nhung, Dean of Medicine at University of Medicine and Pharmacy, Vietnam National University (VNU) Hanoi.
Health experts called for collective disease prevention and integrated solutions to achieve zero dengue deaths in the country at an online talk show on June 14.
The PM called for closer, broader, and more effective cooperation with Vietnamese partners, guided by the principles of mutual benefit, joint efforts, shared outcomes, and common development, including promoting stronger public-private partnerships and collaboration with businesses.
Renowned for its expertise in complex surgeries, the hospital has attracted foreign patients seeking treatment for conditions such as kidney and urinary tract stones, urological and gastrointestinal cancers, and male reproductive disorders. Most procedures are performed using advanced techniques, including laparoscopy and robotic surgery. T
Leading Vietnamese companies specialising in respiratory and dermatological treatments, traditional medicine, immune support supplements, and functional foods will have an opportunity to connect with international distributors and secure export deals.
The project aimed to enable early detection and reduce the risk of dangerous complications, targeting patients with chronic diabetes, cardiovascular conditions and metabolic disorders.
A 2023 report by the Vietnam Health Economics Association estimated that the total cost of tobacco-related healthcare and economic losses reached 108 trillion VND (4.14 billion USD) annually – equivalent to 1.14% of GDP and five times higher than the budget revenue generated by the tobacco industry.
All eligible patients will receive surgical interventions and post-operative care in accordance with Vietnamese medical standards and global care protocols.
Medical screenings and surgical interventions for children with disabilities are being carried out at health centers across Dien Bien. So far this year, 242 children have been identified for diagnosis, treatment, surgery, and the provision of assistive devices.
The Red Journey has become the country’s largest and most effective blood donation campaign, leaving a strong impression on the national voluntary blood donation movement.
This case marks the ninth fetal cardiac intervention conducted in HCM City, and it was considered the most technically demanding to date due to the fetus’s extremely early gestational age and the severity of the condition as diagnosed with aortic atresia.
The groundbreaking ceremony took place one day after the VNVC Vaccine JS Company and Sanofi Group exchanged cooperation documents on vaccine production technology transfer under the witness of State President Luong Cuong and French President Emmanuel Macron.
Vietnam’s traditional medicine took centre stage at the International Congress Biopharm Nonclinical Development, BioNCiD 2025, held on May 25-26 in the Cuban city of Varadero, amid growing global interest in sustainable healthcare solutions.
Under the agreement, VNVC and Sanofi will gradually implement technology transfers to enable domestic production of several key Sanofi vaccines that are widely used in Vietnam. In addition, Sanofi will support VNVC in training human resources and quality management in vaccine research and manufacturing.
Despite the ongoing global circulation and unpredictable developments of SARS-CoV-2, the World Health Organisation (WHO) hasn’t issued new warnings about COVID-19, said the Ministry of Health.
A medial worker prepares to inject Nanocovax, the first made-in-Vietnam COVID-19 vaccine, into a volunteer as part of human trials on December 17, 2020 (Photo: VNA) 
